BHST

BIOHARVEST SCIENCES INC. BHST

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $25.2M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Revenue

$25.19M

Quarter to Dec 31

Net income

$-12.91M

Quarter to Dec 31

Free cash flow

$-9.52M

Quarter to Dec 31

Operating margin

-27.8%

Quarter to Dec 31

Top Institutional Holders

as of Q2 2026
$4.80M total
Alyeska Investment Group, L.P.
$1.66M-23.2%
THOMPSON SIEGEL & WALMSLEY LLC
$1.04M-5.9%
Evercore Wealth Management, LLC
$618.7K+55.1%
True North Advisors, LLC
$535.7K+11.5%
Magnus Financial Group LLC
$257.4K+63.6%
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$179.5K+288.3%
Silverberg Bernstein Capital Management LLC
$162.8K+121.2%
KING LUTHER CAPITAL MANAGEMENT CORP
$114.4K0.0%
TD Waterhouse Canada Inc.
$65.5K0.0%
CITADEL ADVISORS LLC
$58.2K+40.0%
XTX Topco Ltd
$37.3K-55.4%
GEODE CAPITAL MANAGEMENT, LLC
$29.8K-10.6%
K.J. Harrison & Partners Inc
$27.9KNew
MORGAN STANLEY
$9.3K0.0%
OSAIC HOLDINGS, INC.
$1.6K-9.1%
UBS Group AG
$495-72.5%
NATIONAL BANK OF CANADA /FI/
$4230.0%
Caitong International Asset Management Co., Ltd
$6New
ROYAL BANK OF CANADA
$0-99.7%
See all 19 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

FY 2024
EDGAR

Net Income

FY 2024
EDGAR

Operating Margin

FY 2024
EDGAR

Free Cash Flow

FY 2024
EDGAR

Debt/Equity

FY 2024
EDGAR

Loading ratio trend…

BHST key financials by period

Reported revenue, net income and operating margin by fiscal year, from BIOHARVEST SCIENCES INC.'s annual filings on SEC EDGAR.

BIOHARVEST SCIENCES INC. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2024$25.2M$-12.9M-27.8%
FY 2023$12.7M$-12.6M-78.6%
Source: BHST filings on SEC EDGAR →

About BIOHARVEST SCIENCES INC. (BHST): stock profile, AI score and financials

BIOHARVEST SCIENCES INC. (BHST) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. BHST is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $25.2m in revenue and is scored on the micro-cap board instead. Based on the latest XBRL financial filings (FY 2024), BIOHARVEST SCIENCES INC. reports quarterly revenue of $25.2M, net income of $-12.9M, an operating margin of -27.8%. Top institutional holders of BHST by reported 13-F value include Alyeska Investment Group, L.P., THOMPSON SIEGEL & WALMSLEY, Evercore Wealth Management, based on the most recent SEC filings. BHST trades on the Nasdaq exchange and files with the SEC under CIK 1723464. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate BHST daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for BIOHARVEST SCIENCES INC. directly from SEC EDGAR.

SEC EDGAR: CIK 1723464 →